Treatment with biologics of pregnant patients with rheumatic diseases

Ostensen, Monika; Förger, Frauke (2011). Treatment with biologics of pregnant patients with rheumatic diseases. Current opinion in rheumatology, 23(3), pp. 293-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/BOR.0b013e328344a732

Full text not available from this repository. (Request a copy)

Due to limited human pregnancy experience safety issues in regard to children exposed antenatally to biological drugs are still under debate. A survey of new published experience on biological agents during pregnancy is necessary to assist clinicians with adequate counseling and management of patients who desire children.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Oestensen, Monika Elisabeth and Förger, Frauke

ISSN:

1040-8711

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:26

Last Modified:

06 Dec 2013 13:30

Publisher DOI:

10.1097/BOR.0b013e328344a732

PubMed ID:

21346578

Web of Science ID:

000288939100014

URI:

https://boris.unibe.ch/id/eprint/9314 (FactScience: 215012)

Actions (login required)

Edit item Edit item
Provide Feedback